# Gender-Associated Differences in the Regulation of Potassium Channels in Astrocytes of Type 2 Diabetic Mice

**Authors:** Luis A. Rojas-Colón, David E. Rivera-Aponte, Jadier Colón-Vázquez, Arelys A. Angueira-Laureano, Miled A. Maisonet-Nieves, Misty J. Eaton, Yanitza Hernández, Christian J. Malpica-Nieves, Serguei N. Skatchkov, Miguel P. Méndez-González

PMC · DOI: 10.3390/cells15040330 · Cells · 2026-02-11

## TL;DR

Diabetes impairs potassium channels in brain cells, with a stronger effect in males, which could increase seizure risk.

## Contribution

The study reveals sex differences in Kir4.1 channel downregulation in diabetic mice, highlighting a potential target for anti-diabetic treatments.

## Key findings

- Diabetic male mice show more severe Kir4.1 channel downregulation than females.
- Hyperglycemia reduces Kir4.1 protein synthesis and potassium uptake in astrocytes.
- Barium-insensitive currents increase in diabetic mice, possibly compensating for channel dysfunction.

## Abstract

What are the main findings?
Kir4.1 channels are downregulated in diabetes in both sexes.Diabetic db/db male mice have a larger impact on their Kir4.1 channel than females.

Kir4.1 channels are downregulated in diabetes in both sexes.

Diabetic db/db male mice have a larger impact on their Kir4.1 channel than females.

What are the implications of the main findings?
Kir4.1 channels should be the focus of anti-diabetic treatments.Since Kir4.1 may be partially recovered by aminoguanidine as was recently shown, the polyamine strategy needs to be investigated further.

Kir4.1 channels should be the focus of anti-diabetic treatments.

Since Kir4.1 may be partially recovered by aminoguanidine as was recently shown, the polyamine strategy needs to be investigated further.

Hyperglycemia is linked to a higher risk of diabetes, epilepsy, and seizures, which contribute to increased mortality. Previous research has shown that hyperglycemia impairs the function of the polyamine-dependent Kir4.1 channels in cultured astrocytes, and a similar effect was observed in male astrocytes from diabetic (db/db) mice. However, whether there are sex differences in this effect remains unclear. This study aims to compare Kir4.1 channel function in 10–12 week old brains of female db/db mice with that in males and non-diabetic heterozygous (db/+). We performed mRNA analyses, Western blotting (WB), glucose level measurements, and patch-clamp recordings from hippocampal astrocytes in brain slices to assess Kir4.1 channel activity in db/db and db/+ mice of both sexes. Our results showed increased glucose levels in diabetic db/db mice, especially in males, along with (1) reduced synthesis of Kir4.1 channel protein, (2) reduced membrane potential, (3) decreased Kir currents, and (4) compromised potassium uptake. Female diabetic astrocytes exhibited significantly lower barium-blocked Kir4.1 currents compared to diabetic males. Additionally, barium-insensitive currents (leakage currents) were upregulated in db/db mice, likely as a compensatory response to hyperglycemia. In conclusion, diabetes impairs astrocyte function by downregulating Kir4.1 channels, with a more pronounced effect in male diabetic mice. This impairment may increase seizure risk by affecting the ability of astrocytes to maintain extracellular ion balance.

## Linked entities

- **Genes:** KCNJ10 (potassium inwardly rectifying channel subfamily J member 10) [NCBI Gene 3766]
- **Chemicals:** aminoguanidine (PubChem CID 2146)
- **Diseases:** Type 2 diabetes (MONDO:0005148), epilepsy (MONDO:0005027)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Nr3c1 (nuclear receptor subfamily 3, group C, member 1) [NCBI Gene 14815] {aka GR, Grl-1, Grl1}, Kcnj10 (potassium inwardly-rectifying channel, subfamily J, member 10) [NCBI Gene 16513] {aka BIR10, BIRK-1, Kir1.2, Kir4.1}, Kcnj8 (potassium inwardly-rectifying channel, subfamily J, member 8) [NCBI Gene 16523] {aka Kir6.1, gnite, slmbr, sltr, uKATP-1}, Kcnk1 (potassium channel, subfamily K, member 1) [NCBI Gene 16525] {aka TWIK-1}, Kcnk10 (potassium channel, subfamily K, member 10) [NCBI Gene 72258] {aka 1700024D23Rik, 3010005K24Rik, Trek2}, Tfrc (transferrin receptor) [NCBI Gene 22042] {aka 2610028K12Rik, CD71, E430033M20Rik, Mtvr1, TFR, TFR1}, Syt17 (synaptotagmin XVII) [NCBI Gene 110058] {aka Bk, sytXVII}, Kcnk2 (potassium channel, subfamily K, member 2) [NCBI Gene 16526] {aka A430027H14Rik, K2P2.1, TREK-1}, Kcnj16 (potassium inwardly-rectifying channel, subfamily J, member 16) [NCBI Gene 16517] {aka 6430410F18Rik, Kir5.1}, Gfap (glial fibrillary acidic protein) [NCBI Gene 14580], Abcc8 (ATP-binding cassette, sub-family C member 8) [NCBI Gene 20927] {aka D930031B21Rik, SUR1, Sur}, Kcnk3 (potassium channel, subfamily K, member 3) [NCBI Gene 16527] {aka TASK, Task-1, cTBAK-1}, Zic3 (zinc finger protein of the cerebellum 3) [NCBI Gene 22773] {aka Bn, Ka}, Hcrt (hypocretin) [NCBI Gene 15171] {aka PPOX}, Lepr (leptin receptor) [NCBI Gene 16847] {aka B219, LEP-R, LEPROT, Leprb, Modb1, OB-RGRP}, Kcnk9 (potassium channel, subfamily K, member 9) [NCBI Gene 223604] {aka A930009L07Rik, Task3}
- **Diseases:** central nervous system disorders (MESH:D002493), Diabetes (MESH:D003920), ischemic (MESH:D002545), Huntington's (MESH:D006816), Alzheimer's (MESH:D000544), mitochondrial dysfunction (MESH:D028361), Hyperglycemia (MESH:D006943), inflammation (MESH:D007249), injury to (MESH:D014947), Neurodegenerative diseases (MESH:D019636), hyperactivity (MESH:D006948), Seizure (MESH:D012640), ischemia (MESH:D007511), retinopathy (MESH:D058437), EAST syndrome (MESH:C557674), obese (MESH:D009765), Acidosis (MESH:D000138), diabetic retinopathy (MESH:D003930), ischemic stroke (MESH:D002544), hypoglycemia (MESH:D007003), death (MESH:D003643), Hyperglycemic (MESH:D006944), brain injury (MESH:D001930), brain diseases (MESH:D001927), amyotrophic lateral sclerosis (MESH:D000690), epilepsy (MESH:D004827), chronic (MESH:D002908), cognitive decline (MESH:D003072), CNS disorders (MESH:D002494), diabetic peripheral neuropathy (MESH:D010523), epileptiform activity (MESH:D014277), neuronal degeneration (MESH:D009410), Type 2 Diabetic (MESH:D003924)
- **Chemicals:** polyacrylamide (MESH:C016679), Triton X-100 (MESH:D017830), bromophenol blue (MESH:D001978), EDTA (MESH:D004492), estradiol (MESH:D004958), lactate (MESH:D019344), NaCl (MESH:D012965), leupeptin (MESH:C032854), bestatin (MESH:C012211), aminoguanidine (MESH:C004479), MgCl2 (MESH:D015636), Blood Glucose (MESH:D001786), glutamate (MESH:D018698), progesterone (MESH:D011374), SDS (MESH:D012967), CaCl2 (MESH:D002122), spermine (MESH:D013096), streptozotocin (MESH:D013311), testosterone (MESH:D013739), metformin (MESH:D008687), water (MESH:D014867), putrescine (MESH:D011700), urea (MESH:D014508), PMSF (MESH:D010664), HEPES (MESH:D006531), Ba2+ (MESH:C080430), K (MESH:D011188), NaH2PO4 (-), NaHCO3 (MESH:D017693), Barium (MESH:D001464), D-glucose (MESH:D005947), pepstatin (MESH:C031375), spermidine (MESH:D013095), KCl (MESH:D011189), KOH (MESH:C029943), glutamine (MESH:D005973), CO2 (MESH:D002245), EGTA (MESH:D004533), ATP (MESH:D000255), polyamine (MESH:D011073)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12939137/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939137/full.md

## References

115 references — full list in the complete paper: https://tomesphere.com/paper/PMC12939137/full.md

---
Source: https://tomesphere.com/paper/PMC12939137